Episode Synopsis "Rare Disease Trials in the Age of COVID: The Patient Perspective"

Rare Disease trials are complex under the best of circumstances—and the coronavirus pandemic has only complicated things. In this podcast, Precision’s Thijs Opdeweegh, Director, Clinical Business Solutions, and Kristi Clark, Senior Vice President, Project Management and Clinical Operations, explore the impact of decentralized operations on rare disease patients, and which new approaches are likely to become the “new normal” after COVID.

Listen "Rare Disease Trials in the Age of COVID: The Patient Perspective"

More episodes of the podcast Rarefied Thinking

• Rare Disease Trials in the Age of COVID: The Patient Perspective